Jiazheng Sun

Chongqing Key Laboratory Of Molecular Oncology And Epigenetics
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lung cancer.

Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lung cancer.

Journal: Science advances

Published: July 17, 2026

Machine Learning-Based Pathomics Signature for Perineural Invasion in Colorectal Cancer.

Machine Learning-Based Pathomics Signature for Perineural Invasion in Colorectal Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: October 10, 2025

Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.

Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.

Journal: Nature communications

Published: August 11, 2025

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

Journal: Nature communications

Published: August 22, 2024

Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.

Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.

Journal: Signal transduction and targeted therapy

Published: August 20, 2024

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Journal: The Journal of clinical investigation

Published: May 29, 2024

Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.

Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.

Journal: Cancer immunology research

Published: May 20, 2024

Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.

Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.

Journal: Journal for immunotherapy of cancer

Published: November 21, 2023

Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion.

Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion.

Journal: Frontiers in immunology

Published: July 19, 2023

Clinicopathological Features of Breast Cancer in Relation to Exposure of Cycling Reproductive Hormones: A Multicenter Retrospective Study of 14,731 Patients Diagnosed with Invasive Breast Cancer.

Clinicopathological Features of Breast Cancer in Relation to Exposure of Cycling Reproductive Hormones: A Multicenter Retrospective Study of 14,731 Patients Diagnosed with Invasive Breast Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: November 30, 2022

Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.

Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.

Journal: Journal of translational medicine

Published: October 21, 2022

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.

Journal: Theranostics

Published: November 12, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026